Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL
LI LIU, GREGER, James, HONG SHI, YUAN LIU, GRESHOCK, Joel, ANNAN, Roland, HALSEY, Wendy, SATHE, Ganesh M, MARTIN, Anne-Marie, GILMER, Tona M
Published in Cancer research (Chicago, Ill.) (01.09.2009)
Published in Cancer research (Chicago, Ill.) (01.09.2009)
Get full text
Journal Article
Concurrent MEK2 Mutation and BRAF Amplification Confer Resistance to BRAF and MEK Inhibitors in Melanoma
Villanueva, Jessie, Infante, Jeffrey R., Krepler, Clemens, Reyes-Uribe, Patricia, Samanta, Minu, Chen, Hsin-Yi, Li, Bin, Swoboda, Rolf K., Wilson, Melissa, Vultur, Adina, Fukunaba-Kalabis, Mizuho, Wubbenhorst, Bradley, Chen, Thomas Y., Liu, Qin, Sproesser, Katrin, DeMarini, Douglas J., Gilmer, Tona M., Martin, Anne-Marie, Marmorstein, Ronen, Schultz, David C., Speicher, David W., Karakousis, Giorgos C., Xu, Wei, Amaravadi, Ravi K., Xu, Xiaowei, Schuchter, Lynn M., Herlyn, Meenhard, Nathanson, Katherine L.
Published in Cell reports (Cambridge) (26.09.2013)
Published in Cell reports (Cambridge) (26.09.2013)
Get full text
Journal Article
Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells
KONECNY, Gottfried E, PEGRAM, Mark D, KEITH, Barry R, GILMER, Tona M, BERGER, Mark, PODRATZ, Karl C, SLAMON, Dennis J, VENKATESAN, Natarajan, FINN, Richard, GUORONG YANG, RAHMEH, Martina, UNTCH, Michael, RUSNAK, David W, SPEHAR, Glenn, MULLIN, Robert J
Published in Cancer research (Chicago, Ill.) (01.02.2006)
Published in Cancer research (Chicago, Ill.) (01.02.2006)
Get full text
Journal Article
Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity
Kumar, Rakesh, Knick, Victoria B, Rudolph, Sharon K, Johnson, Jennifer H, Crosby, Renae M, Crouthamel, Ming-Chih, Hopper, Teresa M, Miller, Charles G, Harrington, Laura E, Onori, James A, Mullin, Robert J, Gilmer, Tona M, Truesdale, Anne T, Epperly, Andrea H, Boloor, Amogh, Stafford, Jeffrey A, Luttrell, Deirdre K, Cheung, Mui
Published in Molecular cancer therapeutics (01.07.2007)
Published in Molecular cancer therapeutics (01.07.2007)
Get full text
Journal Article
Inhibition of the Growth of Patient-Derived Pancreatic Cancer Xenografts with the MEK Inhibitor Trametinib Is Augmented by Combined Treatment with the Epidermal Growth Factor Receptor/HER2 Inhibitor Lapatinib
Walters, Dustin M, Lindberg, James M, Adair, Sara J, Newhook, Timothy E, Cowan, Catharine R, Stokes, Jayme B, Borgman, Cheryl A, Stelow, Edward B, Lowrey, Bryce T, Chopivsky, Maria E, Gilmer, Tona M, Parsons, John T, Bauer, Todd W
Published in Neoplasia (New York, N.Y.) (01.02.2013)
Published in Neoplasia (New York, N.Y.) (01.02.2013)
Get full text
Journal Article
Delineation of molecular mechanisms of sensitivity to lapatinib in breast cancer cell lines using global gene expression profiles
Hegde, Priti S, Rusnak, David, Bertiaux, Melissa, Alligood, Krystal, Strum, Jay, Gagnon, Robert, Gilmer, Tona M
Published in Molecular cancer therapeutics (01.05.2007)
Published in Molecular cancer therapeutics (01.05.2007)
Get full text
Journal Article
In vitro biological activity of a novel small-molecule inhibitor of polo-like kinase 1
Lansing, Timothy J, McConnell, Randy T, Duckett, Derek R, Spehar, Glenn M, Knick, Victoria B, Hassler, Daniel F, Noro, Nobuhiro, Furuta, Masaaki, Emmitte, Kyle A, Gilmer, Tona M, Mook, Jr, Robert A, Cheung, Mui
Published in Molecular cancer therapeutics (01.02.2007)
Published in Molecular cancer therapeutics (01.02.2007)
Get full text
Journal Article
Impact of Common Epidermal Growth Factor Receptor and HER2 Variants on Receptor Activity and Inhibition by Lapatinib
GILMER, Tona M, CABLE, Louann, WOOD, Edgar R, ALLIGOOD, Krystal, RUSNAK, David, SPEHAR, Glenn, GALLAGHER, Kathleen T, WOLDU, Ermias, CARTER, H. Luke, TRUESDALE, Anne T, SHEWCHUK, Lisa
Published in Cancer research (Chicago, Ill.) (15.01.2008)
Published in Cancer research (Chicago, Ill.) (15.01.2008)
Get full text
Journal Article
Evaluation of Lapatinib and Topotecan Combination Therapy: Tissue Culture, Murine Xenograft, and Phase I Clinical Trial Data
MOLINA, Julian R, KAUFMANN, Scott H, JEWELL, Roxanne C, FELTEN, Sara J, MANDREKAR, Sumithra, ADJEI, Alex A, ERLICHMAN, Charles, REID, Joel M, RUBIN, Stephen D, GALVEZ-PERALTA, Marina, FRIEDMAN, Robert, FLATTEN, Karen S, KOCH, Kevin M, GILMER, Tona M, MULLIN, Robert J
Published in Clinical cancer research (01.12.2008)
Published in Clinical cancer research (01.12.2008)
Get full text
Journal Article
Combinations of BRAF, MEK, and PI3K/mTOR inhibitors overcome acquired resistance to the BRAF inhibitor GSK2118436 dabrafenib, mediated by NRAS or MEK mutations
Greger, James G, Eastman, Stephen D, Zhang, Vivian, Bleam, Maureen R, Hughes, Ashley M, Smitheman, Kimberly N, Dickerson, Scott H, Laquerre, Sylvie G, Liu, Li, Gilmer, Tona M
Published in Molecular cancer therapeutics (01.04.2012)
Published in Molecular cancer therapeutics (01.04.2012)
Get full text
Journal Article
A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors
Gilmer, Tona M, Lai, Chun-Hsiang, Guo, Kexiao, Deland, Katherine, Ashcraft, Kathleen A, Stewart, Amy E, Wang, Yaode, Fu, Jianmin, Wood, Kris C, Kirsch, David G, Kastan, Michael B
Published in Molecular cancer therapeutics (04.06.2024)
Published in Molecular cancer therapeutics (04.06.2024)
Get full text
Journal Article
Identification of Both Positive and Negative Domains within the Epidermal Growth Factor Receptor COOH-terminal Region for Signal Transducer and Activator of Transcription (STAT) Activation
Xia, Ling, Wang, Lijuan, Chung, Alicia S, Ivanov, Stanimir S, Ling, Mike Y, Dragoi, Ana M, Platt, Adam, Gilmer, Tona M, Fu, Xin-Yuan, Chin, Y Eugene
Published in The Journal of biological chemistry (23.08.2002)
Published in The Journal of biological chemistry (23.08.2002)
Get full text
Journal Article
The Translational Research Working Group Developmental Pathway for Anticancer Agents (Drugs or Biologics)
Schilsky, Richard L, Gordon, Gary, Gilmer, Tona M, Courtneidge, Sara A, Matrisian, Lynn M, Grad, Oren, Nelson, William G
Published in Clinical cancer research (15.09.2008)
Published in Clinical cancer research (15.09.2008)
Get full text
Journal Article
Synergistic effects of foretinib with HER-targeted agents in MET and HER1- or HER2-coactivated tumor cells
Liu, Li, Shi, Hong, Liu, Yuan, Anderson, Amber, Peterson, John, Greger, James, Martin, Anne-Marie, Gilmer, Tona M
Published in Molecular cancer therapeutics (01.03.2011)
Published in Molecular cancer therapeutics (01.03.2011)
Get full text
Journal Article
A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): Relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells
WOOD, Edgar R, TRUESDALE, Anne T, ALLIGOOD, Krystal J, RUSNAK, David W, GILMER, Tona M, SHEWCHUK, Lisa, MCDONALD, Octerloney B, YUAN, Derek, HASSELL, Anne, DICKERSON, Scott H, ELLIS, Byron, PENNISI, Christopher, HORNE, Earnest, LACKEY, Karen
Published in Cancer research (Chicago, Ill.) (15.09.2004)
Published in Cancer research (Chicago, Ill.) (15.09.2004)
Get full text
Journal Article
Characterization of an Akt Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity
RHODES, Nelson, HEERDING, Dirk A, KAHANA, Jason A, GESKE, Robert S, KIEYMENOVA, Elena V, CHOUDHRY, Anthony E, ZHIHONG LAI, LEBER, Jack D, MINTHORN, Elisabeth A, STRUM, Susan L, WOOD, Edgar R, HUANG, Pearl S, DUCKETT, Derek R, COPELAND, Robert A, KUMAR, Rakesh, EBERWEIN, Derek J, KNICK, Victoria B, LANSING, Timothy J, MCCONNELL, Randy T, GILMER, Tona M, ZHANG, Shu-Yun, ROBELL, Kimberly
Published in Cancer research (Chicago, Ill.) (01.04.2008)
Published in Cancer research (Chicago, Ill.) (01.04.2008)
Get full text
Journal Article
The Effects of the Novel, Reversible Epidermal Growth Factor Receptor/ErbB-2 Tyrosine Kinase Inhibitor, GW2016, on the Growth of Human Normal and Tumor-derived Cell Lines in Vitro and in Vivo
Rusnak, D W, Lackey, K, Affleck, K, Wood, E R, Alligood, K J, Rhodes, N, Keith, B R, Murray, D M, Knight, W B, Mullin, R J, Gilmer, T M
Published in Molecular cancer therapeutics (01.12.2001)
Get full text
Published in Molecular cancer therapeutics (01.12.2001)
Journal Article
The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: Potential therapy for cancer
RUSNAK, David W, AFFLECK, Karen, JOWETT, Amanda, STABLES, Jeremy, TOPLEY, Peter, WOOD, Edgar R, BRIGNOLA, Perry S, KADWELL, Sue H, REEP, Bryan R, MULLIN, Robert J, ALLIGOOD, Krystal J, KEITH, Barry R, COCKERILL, Stuart G, CROSBY, Renae M, MURRAY, Doris M, KNIGHT, W. Blaine, GILMER, Tona M, LACKEY, Karen, STUBBERFIELD, Colin, HARRIS, Robert, PAGE, Martin, SMITH, Kathryn J, GUNTRIP, Stephen B, CARTER, Malcolm C, SHAW, Robert J
Published in Cancer research (Chicago, Ill.) (01.10.2001)
Get full text
Published in Cancer research (Chicago, Ill.) (01.10.2001)
Journal Article